Partner with Us
SCROLL

Harnessing the power of digital to improve medicine

Remepy enables pharma companies to launch software-drug combinations. Each of our apps is tailored to specific clinical indications and drug mechanisms of action, increasing the drug’s efficacy. Engagement with our apps activates brain mechanisms with downstream impact on the immune system as well as direct improvement of synaptic connectivity and neuroplasticity.

Digital Molecule™

The core of Remepy’s apps is the Digital MoleculeTM. This is a unique digital intervention protocol created by Remepy’s scientists, tailored for each clinical indication, specific drug mechanism, drug treatment protocol and patient journey. The Digital MoleculeTM has a synergistic effect on a molecular level with each drug, increasing its efficacy, as well addressing specific co-morbidities and side effects. Our initial Digital MoleculesTM focus on immune system modulation as well as on synaptic connectivity and neuro-plasticity.


Our apps include several additional key modules:

Patient check-in
Personalized symptom checker. Digital efficacy tracking. Humanized check-in, that is responsive to patient responses. Safe Place(™) in response to sever symptoms.
Companion
Reminders, daily journal, gamification, notifications and tracking adapted to treatment schedule for improved adherence. Special prep prior to hospital visits including Pet CT. 
Care Cycle
Family and provider access, notifications and reports
Reports and analytics
Family and provider access, notifications and reports.
Drug Specific
Branded and tailored to specific disease and drug.
Security and Privacy
Our platform adheres to the highest standards of security and privacy and is HIPAA compliant.
Patient Communities
Connect, share and learn from each other
Inspired by nature.
Perfected by science.

Remepy interventions have a two-pronged approach to improving patient outcomes. These precise interventions, together with drug molecules creates a new mechanism of action, in the form of a software-drug combination.

Psychological and cognitive interventions can restore neuro-endocrine and neuro-immunological balance by influencing hormones such as cortisol and adrenaline as well as cytokines such as IL-6 and INFγ.

This immunological rebalancing creates better conditions for improved pharmacokinetics and pharmacodynamics, directly enhancing efficacy and safety profiles of drugs.

Our evidence-based psychological interventions are also used to directly reduce comorbidities and medication side effects such as depression, anxiety, fatigue, and pain. This can have an overall improvement in patients' quality of life.

By reprogramming the adult brain, Remepy’s interventions can increase synaptic connectivity and influence brain areas that enhance patients’ ability to self-regulate and deal with negative emotions and pain.

Increased brain connectivity can help prevent excessive stress-related activation of the hypothalamic-pituitary axis, further rebalancing the immune system.

By rewiring  the brain and balancing the immune system, our interventions foster optimal conditions for enhanced drug effect and improved disease outcomes in many neurodegenerative diseases, such as Alzheimer’s disease.

Leading the way

Remepy’s vision has been to enhance medicine by digitally invoking natural processes in our body.

There is a tremendous opportunity to rewrite the drug development process by harnessing the power of our digital world.

We have assembled a unique multidisciplinary team of software engineers, scientists, immunologists, physicians, psychologists, drug developers, computer scientists, and entrepreneurs to form a new kind of company, made possible by advances in technology, patient data and improved understanding of natural immune processes.

Or Shoval
CEO

Captain Special Ops.
IDF Product & Program Management

Dr. Michal Tsur
Chairperson

Co-founder and President Kaltura
Co-founder Cyota

Prof. Amir Amedi
Chief Scientific Officer

Head of Brain Cognition & Tech,
RU Institution, Harvard & HUJI

Dr. Shahar Shelly
Chief Medical Officer

Neurologist, Mayo Clinic, Rambam

Prof. Michal Schwartz
Scientific Advisor

International Neuroimmunology KOL. Weizmann Institute.

Dr. Shai Elrich
Chief Development Officer

Chief Medical Officer & President of US Operations, Quark Pharmaceuticals

Dr. Nira Saporta
Head of Therapeutics

Cyota, PayPal, Kaltura.
Clinical Psychologist

Noam Livnat
Chief Product Officer

Co-founder & VP Product WatchDoxSr. Dir Product MarkMonitor

Prof. Ofer Tur-Sinai
General Counsel

IP Expert, HUJI & OAC

Johnathan Amit-Kanarek
CTO

CTO at PeechSystem Architect
at Kaltura

Partner with us to redefine
drug therapy and create

software-drug combination.

Partner with Us
© Copyright 2023 Remepy Health Ltd.